Numerous changes to the Medicare Advantage landscape in 2027—including changes to plan, provider network, and benefit availability—increase the need for payer-provider collaboration.
The latest wave of AI pilots and partnerships is an important testing ground as organizations will need to move deliberately and stay responsive to what clinicians and patients are already asking for.
As multiple new 340B policies could coincide in 2027, providers face impacts to their eligibility, reimbursement levels, cash flow, and administrative burdens. We discuss implications and next steps.
While hospital finances have recovered, performance still lags pre-pandemic levels. To navigate ongoing headwinds, health systems must build a durable operating model.
The cancer care ecosystem must keep pace with rising need and accelerating innovation while maintaining financial sustainability. We discuss key changes.
2026 health system partnerships reflect a new phase of M&A that’s laser-focused on achieving enterprise access, affordability, and sustainability goals in a more challenging operating environment.
New and proposed changes could reshape how federal grants are reviewed, awarded, managed, and terminated, raising new risks for healthcare institutions with NIH-funded portfolios.
The long-awaited CMS guidance outlines who qualifies for an exception and the documentation-heavy requirements for proving medical frailty. We discuss implications for hospitals and health systems.
A new report reinforces that healthcare disparities are an increasing performance challenge for health systems. We discuss implications and critical actions.
